Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Utku Seyis"'
Autor:
Cansu Hemşinlioğlu, Elif Sibel Aslan, Cihan Tastan, Didem Çakırsoy, Raife Dilek Turan, Utku Seyis, Muhammer Elek, Gözde Sır Karakuş, Ömür Selin Günaydın, Selen Abanuz, Derya Dilek Kançağı, Bulut Yurtsever, Koray Yalçın, Murat Kasap, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 2, Pp 118-124 (2023)
Objective: Hemophilia A is an X-linked recessive bleeding disorder caused by a deficiency of plasma coagulation factor VIII (FVIII), and it accounts for about 80%-85% of all cases of hemophilia. Plasma-derived therapies or recombinant FVIII concentra
Externí odkaz:
https://doaj.org/article/c4d89b70bef242af9b222fa0e01cf281
Autor:
Koray Yalcin, Ebru Erdogan, Rehile Zengin, Tulay Ozcelik, Nurcan Ozcelik Kurkcu, Hakan Ozdogu, Cem Kis, Gozde Sir Karakus, Selin Gunaydin, Utku Seyis, Siret Ratip, Ercument Ovali
Publikováno v:
HemaSphere, Vol 7, p e6163977 (2023)
Externí odkaz:
https://doaj.org/article/b4e043b7f69148a2a60157e181a335d8
Autor:
Ebru Erdoğan, Koray Yalçın, Cansu Hemşinlioğlu, Aslıhan Sezgin, Utku Seyis, Derya Dilek Kancağı, Cihan Taştan, Bulut Yurtsever, Raife Dilek Turan, Didem Çakırsoy, Selen Abanuz, Gözde Sır Karakuş, Muhammer Elek, Hüseyin Saffet Beköz, Ali İhsan Gemici, Deniz Sargın, Mutlu Arat, Burhan Ferhanoğlu, Ebru Pekgüç, Serdar Örnek, Deram Büyüktaş, Nur Birgen, Siret Ratip, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 3, Pp 206-210 (2022)
Objective: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability
Externí odkaz:
https://doaj.org/article/556bd673500c45ae8473e751960454e8
Autor:
Raife Dilek Turan, Cihan Tastan, Derya Dilek Kancagi, Bulut Yurtsever, Gozde Sir Karakus, Samed Ozer, Selen Abanuz, Didem Cakirsoy, Gamze Tumentemur, Sevda Demir, Utku Seyis, Recai Kuzay, Muhammer Elek, Miyase Ezgi Kocaoglu, Gurcan Ertop, Serap Arbak, Merve Acikel Elmas, Cansu Hemsinlioglu, Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Cavit Kerem Kayhan, Fatma Tokat, Gurler Akpinar, Murat Kasap, Ayse Sesin Kocagoz, Ugur Ozbek, Dilek Telci, Fikrettin Sahin, Koray Yalcin, Siret Ratip, Umit Ince, Ercument Ovali
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract The SARS-CoV-2 virus caused the most severe pandemic around the world, and vaccine development for urgent use became a crucial issue. Inactivated virus formulated vaccines such as Hepatitis A and smallpox proved to be reliable approaches for
Externí odkaz:
https://doaj.org/article/0080510c27ab4fa68a13783ab005d11d
Autor:
Gozde Sir Karakus, Cihan Tastan, Derya Dilek Kancagi, Bulut Yurtsever, Gamze Tumentemur, Sevda Demir, Raife Dilek Turan, Selen Abanuz, Didem Cakirsoy, Utku Seyis, Samed Ozer, Omer Elibol, Muhammer Elek, Gurcan Ertop, Serap Arbak, Merve Acikel Elmas, Cansu Hemsinlioglu, Ayse Sesin Kocagoz, Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Ugur Ozbek, Dilek Telci, Fikrettin Sahin, Koray Yalcin, Siret Ratip, Ercument Ovali
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-19 (2021)
Abstract COVID-19 outbreak caused by SARS-CoV-2 created an unprecedented health crisis since there is no vaccine for this novel virus. Therefore, SARS-CoV-2 vaccines have become crucial for reducing morbidity and mortality. In this study, in vitro an
Externí odkaz:
https://doaj.org/article/46a25aaed32541e28966db05d0693f25
Autor:
Cihan Taştan, Derya Dilek Kançağı, Raife Dilek Turan, Bulut Yurtsever, Didem Çakırsoy, Selen Abanuz, Muhammet Yılancı, Utku Seyis, Samed Özer, Selin Mert, Cavit Kerem Kayhan, Fatma Tokat, Merve Açıkel Elmas, Selçuk Birdoğan, Serap Arbak, Koray Yalçın, Aslıhan Sezgin, Ebru Kızılkılıç, Cansu Hemşinlioğlu, Ümit İnce, Siret Ratip, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 4, Pp 234-247 (2020)
Objective: Relapsed and refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) are the focus of studies on hematological cancers. Treatment of these malignancies has undergone recent transformation with the
Externí odkaz:
https://doaj.org/article/23ae462105714cc7b49d3f11c108d506
Autor:
Cansu Hemsinlioglu, Nil Banu Pelit, Omur Selin Gunaydin, Nihal Ozturk Sahin, Esra Savas Karagacli, Sefa Onur Demir, Evren Safak, Raife Dilek Turan, Goncagul Celebi, Miyase Ezgi Kocaoglu Sen, Zeynep Torun, Utku Seyis, Rehile Zengin, Ayse Sesin Kocagoz, Caglar Cuhadaroglu, Nur Birgen, Siret Ratip, Ercument Ovali
BACKGROUND The efficacy of SARS-CoV2 single donor convalescent plasma (CP) varied according to the application time and the amount of antibody that is administered. Single donor CP has some drawbacks; such as the insufficient levels of neutralizing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b3286eaecda19042444d50d795e508c
https://doi.org/10.21203/rs.3.rs-1042702/v3
https://doi.org/10.21203/rs.3.rs-1042702/v3
Autor:
Cansu Hemşinlioğlu, Elif Sibel Aslan, Cihan Taştan, Didem Çakırsoy, Raife Dilek Turan, Utku Seyis, Muhammer Elek, Gözde Sir Karakuş, Ömur Selin Günaydın, Selen Abanuz, Derya Dilek Kançağı, Bulut Yurtsever, Koray Yalçın9, Murat Kasap, Ercüment Ovalı
Publikováno v:
Turkish Journal of Hematology.
Objective: Hemophilia A is an X-linked recessive bleeding disorder caused by a deficiency of plasma coagulation factor VIII (FVIII), and it accounts for about 80%-85% of all cases of hemophilia. Plasma-derived therapies or recombinant FVIII concentra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef79866a9fff0fe28996e3bea4b6a8aa
https://doi.org/10.4274/tjh.galenos.2023.2022.0318
https://doi.org/10.4274/tjh.galenos.2023.2022.0318
Autor:
Raife Dilek Turan, Omur Selin Gunaydin, Muhammer Elek, Nil Banu Pelit, Ercument Ovali, Sefa Onur Demir, Rehile Zengin, Miyase Ezgi Kocaoglu, Cihan Tastan, Nur Birgen, Nihal Ozturk Sahin, Selen Abanuz, Esra Savas Karagacli, Caglar Cuhadaroglu, Goncagul Celebi, Bulut Yurtsever, Derya Dilek Kancagi, Cansu Hemsinlioglu, Gozde Sir Karakus, Koray Yalcin, Evren Safak, Ayse Sesin Kocagoz, Siret Ratip, Zeynep Torun, Omer Elibol, Didem Cakirsoy, Utku Seyis
Introduction The efficacy of SARS-CoV2 standard single donor convalescent plasma varied according to the application time and most importantly the amount of antibody that is administered. Single donor plasma has some drawbacks; such as the insufficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10f5eff4215dd3b7996e4caf620d74dc
https://doi.org/10.21203/rs.3.rs-1042702/v1
https://doi.org/10.21203/rs.3.rs-1042702/v1
Autor:
Mutlu Arat, Didem Cakirsoy, Selen Abanuz, Ercument Ovali, Bulut Yurtsever, Ali İhsan Gemici, Utku Seyis, Cansu Hemsinlioglu, Serdar Örnek, Gozde Sir Karakus, Huseyin Saffet Bekoz, Siret Ratip, Ebru Pekguc, Aslıhan Sezgin, Raife Dilek Turan, Koray Yalcin, Deniz Sargin, Muhammer Elek, Cihan Tastan, Deram Buyuktas, Burhan Ferhanoglu, Derya Dilek Kancagi, Nur Birgen, Ebru Erdogan
ObjectiveChimeric antigen receptor T (CAR-T) cell therapies already made an impact on the treatment of B cell malignancies. Although CAR-T cell therapies are promising, there are concerns with commercial products regarding their affordability and sus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::572ac870518042265443af4f71a3838d
https://doi.org/10.1101/2021.09.23.21263731
https://doi.org/10.1101/2021.09.23.21263731